Skip to main content
. 2021 Feb 22;8:590448. doi: 10.3389/fsurg.2021.590448

Table 4.

Survival comparison between UTUC-BC and primary BC patients stratified by surgical procedure.

n Median Survival (month) 1-yr OS, % 3-yr OS, % 1-yr!!break CSM, % 3-yr!!break CSM, %
Non-muscle invasive UTUC-BC No surgery of primary site 42 68 (45–NA) 83.2 (72.6–95.4) 66.9 (53.6–83.6) 12.0 22.9
Local tumor treatment or Partial cystectomy 521 68 (54–84) 86.6 (83.7–89.6) 65.6 (61.4–70.1) 6.1 16.2
Radical cystectomy 11 46 (30–NA) 81.8 (61.9–100) 56.1 (30.8–100) 18.2 43.9
Non-muscle invasive primary BC No surgery of primary site 2,946 114 (108–118) 89.8 (89.1–90.4) 78.0 (77.1–79.0) 3.0 5.8
Local tumor treatment or Partial cystectomy 142,054 121 (120–122) 93.9 (93.8–94.0) 82.0 (81.8–82.2) 1.6 4.5
Radical cystectomy 712 122 (115–140) 92.9 (91.9–94.0) 82.0 (80.3–83.8) 3.6 9.4
Non-muscle invasive primary BC after PSM No surgery of primary site 186 91 (79–120) 89.8 (85.5–94.4) 78.5 (72.5–85.0)
Local tumor treatment or Partial cystectomy 2,657 115 (103–121) 92.9 (91.9–93.9) 80.2 (78.6–81.9)
Radical cystectomy 46 86 (69–NA) 91.3 (83.5–99.8) 74.0 (61.8–88.6)
Muscle invasive UTUC-BC No surgery of primary site 3 NA NA NA NA NA
Local tumor treatment or Partial cystectomy 34 11 (5–31) 47.8 (33.3–68.6) 26.9 (14.9–48.7) 39.7 53.8
Radical cystectomy 17 20 (14–36) 76.5 (58.7–99.5) 13.7 (3.9–48.7) 11.8 62.7
Muscle invasive primary BC No surgery of primary site 765 10 (9–11) 42.2 (38.8–46.0) 22.0 (19.1–25.3) 36.1 48.6
Local tumor treatment or Partial cystectomy 18,312 19 (18–19) 61.0 (60.2–61.7) 34.9 (34.2–35.6) 25.9 41.8
Radical cystectomy 12,631 52 (49–56) 79.9 (79.2–80.6) 56.7 (55.8–57.6) 13.7 30.1
Muscle invasive primary BC after PSM No surgery of primary site 6 NA NA NA
Local tumor treatment or Partial cystectomy 160 22 (17–39) 65.0 (57.9–72.9) 41.5 (34.2–50.4)
Radical cystectomy 99 49 (36–77) 81.4 (74.0–89.5) 56.9 (47.4–68.3)

UTUC-BC, bladder recurrence after radical nephroureterectomy of upper urinary tract urothelial carcinoma; BC, bladder cancer; OS, overall survival; CSM, cancer-specific mortality; NA, not available; PSM, propensity score matching.